RAMM Pharma Overview
- Year Founded
-
1988
- Status
-
Public
- Stock Symbol
-
RAMM
- Investments
-
7
RAMM Pharma General Information
Description
RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.
Contact Information
Website
www.wearerammpharma.comCorporate Office
- 82 Richmond Street East
- Suite 200
- Toronto, Ontario M5C 1P1
- Canada
Corporate Office
- 82 Richmond Street East
- Suite 200
- Toronto, Ontario M5C 1P1
- Canada
RAMM Pharma Stock Performance
As of 18-Nov-2026, RAMM Pharma’s current market cap is $835K with 119M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.01 | $835K | 119M | 71.2K | -$0.05 |
RAMM Pharma Financials Summary
As of 31-Jul-2026, RAMM Pharma has a trailing 12-month revenue of $916K.
|
In Thousands, USD |
TTM 31-Jul-2026 | FY 2025 31-Oct-2025 | FY 2024 31-Oct-2024 | FY 2023 31-Oct-2023 |
|---|---|---|---|---|
| EV | 798 | 922 | (48) | 51 |
| Revenue | 916 | 2,396 | 3,190 | 3,753 |
| EBITDA | (6,032) | (5,649) | (11,223) | (4,828) |
| Net Income | (6,551) | (6,352) | (12,123) | (5,721) |
| Total Assets | 4,795 | 6,630 | 12,042 | 23,356 |
| Total Debt | 121 | 57 | 135 | 293 |
RAMM Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
RAMM Pharma Comparisons
Industry
Financing
Details
RAMM Pharma Competitors (2)
One of RAMM Pharma’s 2 competitors is Mandara Pharma, a Corporation company based in Toronto, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mandara Pharma | Corporation | Toronto, Canada | ||||
| Avicanna | Formerly VC-backed | Toronto, Canada |
RAMM Pharma Investments & Acquisitions (7)
RAMM Pharma’s most recent deal was a Merger/Acquisition with HemPoland for . The deal was made on 06-Sep-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| HemPoland | 06-Sep-2022 | Merger/Acquisition | Personal Products | ||
| Canapar | 14-Jun-2021 | Merger/Acquisition | Cultivation | ||
| Canapar | 04-Jan-2021 | Corporate | Cultivation | ||
| Canapar | 30-Dec-2020 | Secondary Transaction - Private | Cultivation | ||
| NettaLife | 04-Jun-2020 | Merger/Acquisition | Other Consumer Non-Durables |
RAMM Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Food Products
Industry
Rank
Percentile
Packaged Foods
Subindustry
Rank
Percentile
RAMM Pharma Exits (1)
RAMM Pharma’s most recent exit was on 03-May-2019 from Medicplast. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Medicplast | 03-May-2019 | Completed |
|
RAMM Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| HemPoland | Elblag, Poland | 2014 |
RAMM Pharma FAQs
-
When was RAMM Pharma founded?
RAMM Pharma was founded in 1988.
-
Where is RAMM Pharma headquartered?
RAMM Pharma is headquartered in Toronto, Canada.
-
What industry is RAMM Pharma in?
RAMM Pharma’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is RAMM Pharma a private or public company?
RAMM Pharma is a Public company.
-
What is RAMM Pharma’s stock symbol?
The ticker symbol for RAMM Pharma is RAMM.
-
What is the current market cap of RAMM Pharma?
The current market capitalization of RAMM Pharma is $835K.
-
What is RAMM Pharma’s current revenue?
The trailing twelve month revenue for RAMM Pharma is $916K.
-
Who are RAMM Pharma’s competitors?
Mandara Pharma and Avicanna are competitors of RAMM Pharma.
-
What is RAMM Pharma’s annual earnings per share (EPS)?
RAMM Pharma’s EPS for 12 months was -$0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process